HealthReveal

HealthReveal is a clinical artificial intelligence company focused on ensuring patients receive evidence-based medical care for chronic conditions. The company's platform utilizes advanced analytics to continuously monitor patient data and compare it against the latest clinical guidelines to identify gaps in care. By providing real-time, actionable insights to healthcare providers and payers, HealthReveal helps prevent adverse health events and improves overall patient outcomes. Its technology specifically targets high-impact chronic diseases such as cardiovascular disease, diabetes, and chronic obstructive pulmonary disease. In 2021, the company was acquired by Accolade to integrate its clinical guidance capabilities into Accolade's personalized healthcare advocacy platform.